Mark Berkhout has a diverse work experience spanning various roles and industries. Mark is currently the Global Head of Male Sexual Health & Medicated Skincare at Cooper Consumer Health, a position they have held since January 2022. Prior to this, they served as the Global Category Director for Medicated Footcare and International Marketing Director at the same company from February 2014 to December 2021.
Mark also has experience in the startup investment sector, working as an investor for startups in marketing, commerce, and adtech at Collider in September and November 2019. Before this, they were the Regional Marketing Director for EMEA/Russia/India at Ormco Europe, a dental platform under Danaher Corporation, from August 2012 to February 2014.
Mark's entrepreneurial spirit led him to co-found and serve as a director for Eyecorp/Identity Eyewear, where they successfully set up two companies selling spectacles in the optician channel and contact lenses in the online, pharmacy, and drugstore channels in the Netherlands and Belgium from January 2007 to July 2012.
Mark also had a significant tenure at Johnson & Johnson, starting as a Marketing Manager for Benelux, Vision Care from March 2002 to June 2003. Mark then progressed to become the EMEA Category Director and EMEA Consumer Marketing Head for Vision Care from June 2003 to September 2006.
Mark's early career includes roles at Henkel's Division Detergents and Household Cleansers, where they served as a Senior Brand Manager for Persil, a flagship heavy-duty detergent, from May 2000 to February 2002. Mark also served as a Brand Manager for Fabric Softeners and Toilet Cleaners from November 1998 to April 2000 and as a Key Account Manager from November 1997 to October 1998. Mark's career at Henkel began as a Trade Marketing Executive from December 1996 to October 1997.
Overall, Mark Berkhout's work experience showcases their diverse skillset and expertise in various industries, including consumer health, dental, eyewear, and household products.
Mark Berkhout has a Bachelor's degree in Business Administration from Nyenrode Business University, which they obtained from 1989 to 1992. Mark later pursued further education and completed a Master's degree in Business Economics from Vrije Universiteit Amsterdam (VU Amsterdam) between 1993 and 1996. In 2019, they attended IMD for a short course called "Leading Digital Business Transformation." No specific field of study was mentioned for this course.
January, 2022 - present
February, 2014
Chief Medical Officer at Immunitas Therapeutics
VP of Applications & Digital Health at University of Pennsylvania Hospital System
SVP & Global Chief Medical Officer at Amarin
Chief Medical Officer at Cerevance
Chief Medical Officer at Affini-T
Access the worlds's biggest network of public org charts
Learn more